Business Context and Reporting Period
This Form 10-Q covers Symantec Corporation (not Gen Digital Inc.) for the quarterly period ended December 31, 1999, and the nine months ended December 31, 1999. Symantec is a leading provider of Internet security technology and consumer software. The company operates on a 52-week fiscal year. During this period, Symantec divested its Visual Cafe and ACT! product lines and acquired Unified Research Laboratories (URLabs).
Key Financial Metrics
| Metric | Three Months Ended Dec 31, 1999 | Nine Months Ended Dec 31, 1999 |
|---|---|---|
| Net Revenues | $200.8 million | $558.5 million |
| Gross Margin | 84.7% | 83.5% |
| Operating Income | $41.3 million | $101.1 million |
| Net Income | $89.0 million | $138.6 million |
| Diluted EPS | $1.41 | $2.27 |
| Cash & Equivalents (Ending) | $213.6 million | $213.6 million |
| Total Cash & Investments | $404.5 million | $404.5 million |
| Long-term Obligations | $0.975 million | $0.975 million |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 29% year-over-year for the quarter and 32% for the nine-month period, driven by strong sales of Norton AntiVirus, Norton 2000, and Norton SystemWorks due to Y2K preparation and virus outbreaks.
- Profitability Surge: Net income increased 460% for the quarter and 445% for the nine-month period. This was significantly boosted by non-recurring gains from divestitures.
- Divestiture Gains: The company recorded a pre-tax gain of approximately $68.5 million from the sale of the Visual Cafe product line and $18.3 million from the licensing of the ACT! product line.
- Expense Increases: Operating expenses rose due to increased R&D and sales headcount, as well as higher amortization of goodwill from recent acquisitions (URLabs, Quarterdeck). Restructuring expenses of $2.2 million were recorded in the quarter for workforce reductions.
Outlook, Risks, and Management Commentary
- Strategic Shift: Management is refocusing on Internet security and enterprise markets, having divested non-core product lines (Visual Cafe, ACT!).
- Future Royalties: Symantec expects to receive quarterly royalty payments from SalesLogix regarding the ACT! license, with a maximum aggregate of $57 million over four years, though amounts are not guaranteed.
- Key Risks:
- Competition: Intense price competition in utility and anti-virus markets; potential feature cannibalization by Microsoft Windows 2000.
- Y2000 Impact: Demand for Y2K-specific products (Norton 2000) is expected to decrease significantly post-rollover.
- Litigation: Ongoing patent infringement claims (e.g., Altiris, Hilgraeve) and a settled class action regarding pre-version 4.0 Norton AntiVirus products. A $3 million accrual was made for settlement costs related to Network Associates litigation.
- Market Volatility: Earnings are subject to significant fluctuations due to end-of-quarter buying patterns and channel inventory levels.
- Liquidity: The company maintains strong liquidity with over $400 million in cash and investments, sufficient to fund operations for the next year without additional financing.
Investor Verification Checklist
- Verify the sustainability of revenue growth post-Y2K, as a significant portion of recent sales was driven by Y2K compliance products.
- Assess the impact of the divestitures on future recurring revenue streams, specifically the non-guaranteed nature of ACT! royalties.
- Monitor the status of pending patent litigation (Altiris, Hilgraeve) and potential future settlement costs.
- Review the amortization schedule for goodwill and intangibles from recent acquisitions (URLabs, Quarterdeck) to understand future expense impacts.
- Confirm the company's ability to maintain gross margins amidst increased price competition and the shift to integrated utility suites.